Israel
· Delayed Price · Currency is ILS · Price in ILAC-Lab Statistics
Total Valuation
C-Lab has a market cap or net worth of ILS 94.13 million. The enterprise value is 62.21 million.
| Market Cap | 94.13M |
| Enterprise Value | 62.21M |
Important Dates
The next estimated earnings date is Wednesday, November 20, 2024.
| Earnings Date | Nov 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
C-Lab has 8.48 million shares outstanding. The number of shares has decreased by -0.44% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 8.48M |
| Shares Change (YoY) | -0.44% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 70.75% |
| Owned by Institutions (%) | 8.08% |
| Float | 2.48M |
Valuation Ratios
The trailing PE ratio is 6.04.
| PE Ratio | 6.04 |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| PB Ratio | 1.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.10 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.33, with an EV/FCF ratio of 4.03.
| EV / Earnings | 4.00 |
| EV / Sales | 0.55 |
| EV / EBITDA | 3.33 |
| EV / EBIT | 3.98 |
| EV / FCF | 4.03 |
Financial Position
The company has a current ratio of 2.94
| Current Ratio | 2.94 |
| Quick Ratio | 1.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 23.13 |
Financial Efficiency
Return on equity (ROE) is 20.13% and return on invested capital (ROIC) is 12.63%.
| Return on Equity (ROE) | 20.13% |
| Return on Assets (ROA) | 7.82% |
| Return on Capital (ROIC) | 12.63% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | 146,877 |
| Employee Count | 106 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.52% in the last 52 weeks. The beta is 0.55, so C-Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -18.52% |
| 50-Day Moving Average | 1,083.84 |
| 200-Day Moving Average | 1,157.87 |
| Relative Strength Index (RSI) | 53.99 |
| Average Volume (20 Days) | 4,181 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, C-Lab had revenue of ILS 113.41 million and earned 15.57 million in profits. Earnings per share was 1.84.
| Revenue | 113.41M |
| Gross Profit | 44.35M |
| Operating Income | 15.64M |
| Pretax Income | 15.59M |
| Net Income | 15.57M |
| EBITDA | 18.53M |
| EBIT | 15.64M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
| Cash & Cash Equivalents | 31.93M |
| Total Debt | n/a |
| Net Cash | 31.93M |
| Net Cash Per Share | 3.76 |
| Equity (Book Value) | 85.77M |
| Book Value Per Share | 10.11 |
| Working Capital | 61.73M |
Cash Flow
In the last 12 months, operating cash flow was 15.88 million and capital expenditures -446,000, giving a free cash flow of 15.43 million.
| Operating Cash Flow | 15.88M |
| Capital Expenditures | -446,000 |
| Free Cash Flow | 15.43M |
| FCF Per Share | 1.82 |
Margins
Gross margin is 39.11%, with operating and profit margins of 13.79% and 13.73%.
| Gross Margin | 39.11% |
| Operating Margin | 13.79% |
| Pretax Margin | 13.75% |
| Profit Margin | 13.73% |
| EBITDA Margin | 16.34% |
| EBIT Margin | 13.79% |
| FCF Margin | 13.61% |
Dividends & Yields
C-Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.44% |
| Shareholder Yield | 0.44% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
C-Lab has an Altman Z-Score of 5.39.
| Altman Z-Score | 5.39 |
| Piotroski F-Score | n/a |